iohexol has been researched along with Left Ventricular Outflow Obstruction in 1 studies
Iohexol: An effective non-ionic, water-soluble contrast agent which is used in myelography, arthrography, nephroangiography, arteriography, and other radiographic procedures. Its low systemic toxicity is the combined result of low chemotoxicity and low osmolality.
iohexol : A benzenedicarboxamide compound having N-(2,3-dihydroxypropyl)carbamoyl groups at the 1- and 3-positions, iodo substituents at the 2-, 4- and 6-positions and an N-(2,3-dihydroxypropyl)acetamido group at the 5-position.
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Dorniak, K | 1 |
| Gałąska, R | 1 |
| Fijałkowski, M | 1 |
| Pieńkowska, J | 1 |
| Łopaciński, T | 1 |
| Węsierska, M | 1 |
1 other study available for iohexol and Left Ventricular Outflow Obstruction
| Article | Year |
|---|---|
Severe left ventricular outflow tract obstruction associated with Kounis syndrome following iodinated contrast administration.
Topics: Contrast Media; Echocardiography; Female; Humans; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Io | 2019 |